POMDOCTOR Ltd (POM) Form 6-K — Nov 4, 2026
POMDOCTOR Limited entered a Debt Conversion Agreement on November 2, 2026 with its PRC operating entity Qilekang and chairman/CEO Zhenyang Shi, converting RMB100,053,000 (US$15,000,000) of debt into 33,185,841 Class A ordinary shares at US$0.452 per share. All shares were issued on November 4, 2026 in offshore Regulation S transactions, fully discharging the Conversion Amount. However, at Mr. Shi's request, a substantial portion of the shares was issued directly to ten designated recipients to satisfy his personal indebtedness, with HEALTHYSEVEN LIMITED receiving 7,546,758 shares.
Key figures
- Gross Proceeds
- 15000000
- Offering Price
- 0.452
- Shares Offered
- 33185841
- Stipulated fx rate
- US$1.00 = RMB6.6702
- Share par value usd
- 0.001
- Conversion amount rmb
- 100053000
- Total acknowledged debt rmb
- 128734825
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.